Immunovant IMVT
NASDAQ IMVT
$34.42 +0.64 (+1.89%)
As of: Oct 1, 2026 · 2:23 PM EDT

Immunovant (IMVT) Long-Term Debt Repayments (2019 - 2021)

Updated

Immunovant's Long-Term Debt Repayments came in at -$3.19 million for fiscal Q4 2021 (quarter ended Mar 31, 2021).

Analysis

Immunovant (IMVT) Long-Term Debt Repayments (2019 - 2021) Analysis & Trends

For FY2020 (ended Mar 31, 2020), Immunovant's Long-Term Debt Repayments was $2.5 million.

  • Business Quant data shows IMVT's Long-Term Debt Repayments at $134,000 (Q3 2021), $202,000 (Q2 2021) and $2.85 million (Q1 2021) in the three fiscal quarters before Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.00 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.45 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 17.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Immunovant 6.97 Bn 6.97 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -3.19 Mn
Dec 31, 2020 134,000.00
Sep 30, 2020 202,000.00
Jun 30, 2020 2.85 Mn
Sep 30, 2019 2.50 Mn
API Access

Immunovant Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=IMVT&period=max&api_key=YOUR_API_KEY